Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
9 11 Search
2024
Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential Inhibitors
Pharmaceuticals
2024
A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Reproductive Sciences
2023
Integrative analysis of gene expression and DNA methylation to identify biomarkers of non-genital warts induced by low-risk human papillomaviruses infection
Heliyon
2023
Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway
Gene
2022
MCM2 in human cancer: functions, mechanisms, and clinical significance
Molecular Medicine
2022
Sequential gene expression analysis of cervical malignant transformation identifies RFC4 as a novel diagnostic and prognostic biomarker
BMC Medicine
2021
RFC4 promotes the progression and growth of Oral Tongue squamous cell carcinoma in vivo and vitro
Journal of Clinical Laboratory Analysis
2021
The upregulated expression of RFC4 and GMPS mediated by DNA copy number alteration is associated with the early diagnosis and immune escape of ESCC based on a bioinformatic analysis
Aging
2021
Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer
International Journal of General Medicine
Additional cited-by details will be shown when available from Crossref